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Abstract: A novel SERS/fluorescent multimodal imaging probe for 
mitochondria has been synthesised using 12 nm diameter gold 
nanoparticles (AuNP) surface functionalised with a rhodamine thiol 
derivative ligand. The normal pH dependant acidic fluorescence of the 
rhodamine based ligand is inversed when conjugated with the AuNP 
and higher emission intensity is observed at basic pH. This switch 
correlates to a pKa at pH 6.62, which makes it an ideal candidate for 
a pH sensitive imaging probe in the biological range (6.5-7.4). The 
observed pH sensitivity when attached to the AuNP is thought to be 
due to the formation of a spirolactam ring on the ligand, going from 
positively charged (+18 mV) to negatively charged (-60 mV) as the pH 
is changed from acidic to basic. Additionally, conjugation of the ligand 
to the AuNP serves to enhance the Raman signal of the rhodamine 
ligand through Surface Enhanced Raman Scattering (SERS). 
Confocal microscopy has shown that the probe enters HEK293 
(kidney), A2780 (ovarian cancer) and Min6 (pancreatic beta) cells 
within an hour and a half incubation time. The probe was shown to 
localise in the mitochondria, thus providing a novel pH dependent 
SERS/fluorescent multimodal imaging probe for mitochondria. 
Introduction 
Molecular imaging is the visualization of the body beyond the 
cellular to the sub-cellular scale. This is where the most 
interesting diagnostic targets for disease are found, and are 
present at low concentrations, typically in the nano- or pico-molar 
range. Molecular imaging has only been possible due to the 
advances in molecular biology and genetics over the past twenty 
years. [1] Molecular imaging utilizes a wide range of diagnostic 
modalities in the clinic, such as magnetic resonance (MR) imaging, 
single photon emission computed tomography (SPECT), positron 
emission tomography (PET), ultrasound and optical imaging (OI). 
[2] However they all suffer draw backs, for instance MR has 
excellent anatomical resolution; but suffers at the molecular scale 
due to its intrinsic low sensitivity. In order to overcome the 
inherent problems of individual modalities, multimodal contrast 
agents is an area of research that shows great promise. This is 
the combination of two or more of these modalities to allow for 
visualization of cellular function and structure in a non-invasive 
manner. [3] 
 
Scheme 1. Synthesis of dual modal fluorescent/Raman probe AuNP.3. (i) 
Diethyl amine, (ii) Lipoic acid, EDC, DMAP, (iii) Methanol, TCEP, NaOH, (iv) 
H2O, sodium citrate. 
In parallel, gold nanoparticles (AuNP) have been successfully 
used in medical applications as nanocarrirers for imaging agents, 
[4] drug delivery and targeted therapy.[5] This is due to the 
reproducible synthesis of specific sizes AuNPs,[6] facile loading 
techniques through surface chemistry [7] and gold’s 
biocompatibility compared to other nanoparticles. As AuNPs do 
not suffer from oxidation effects as quickly as other metallic 
nanoparticles, they can be used for a variety of applications. [7] 
There has been increasing interest in cancer detection and 
[a] C. J. Eling, T. W. Price, G.Firth and Dr G. J. Stasiuk 
School of Life Sciences, Biomedical Section,  
           University of Hull,  
Cottingham road, HU6 7RX, UK 
E-mail: g.stasiuk@hull.ac.uk 
[b] C. J. Eling, A. R. L. Marshall, F. Narda Viscomi, Dr A. Adawi, and Dr 
J-S. G. Bouillard 
School of Mathematics and Physical Sciences, Department of 
Physics and Mathematics,  
University of Hull,  
Cottingham road, HU6 7RX, UK 
[c]  Dr J-S. G. Bouillard 
Department of Physics,  
King’s College London,  
Strand, London, WC2R 2LS 
[d]  Dr G. J. Stasiuk 
Positron Emission Tomography Research Centre,  
University of Hull,  
Cottingham road, HU6 7RX, UK 
[e] Dr A. Adawi, and Dr J-S. G. Bouillard  
G. W. Gray Centre for Advanced Materials 
 University of Hull,  
Cottingham road, HU6 7RX, UK 
 Supporting information for this article is given via a link at the end of 
the document 
  
 
 
 
 
therapy, where AuNPs have been used as hyperthermia therapy 
agents.[5]  
Figure 1. Emission spectra of 3 and AuNP.3, (H2O, 298K), extinction of the 
AuNP, inset TEM of AuNP.3 scale bar 40 nm.  
Additionally, the Localised Surface Plasmon Resonance (LSPR), 
associated with AuNPs can be tuned by engineering the size and 
shape of the nanoparticle. [8] The strong field confinement and 
enhancement linked to the LSPR can be used to enhance Raman 
signals of nearby molecules, including conjugated aromatic 
attached to metallic nanoparticles, resulting in Surface Enhanced 
Raman Scattering (SERS), an ultrasensitive vibrational 
spectroscopic technique. [8] In recent years, SERS has been 
used as an imaging tool for several molecular events. [9] This 
enhancement in Raman signal has recently been applied to 
medical imaging and presents a novel modality as a diagnostic 
tool. [9] In combination with optical imaging, SERS can provide a 
useful tool to obtain information on the local chemical environment 
in vivo. [10] As a result, SERS probes have been used as nano 
sensors for cellular functions including pH, and biomarker 
localisation. [9] These probes use organic fluorophores such as 
Rhodamine 6G in conjunction with AuNPs to obtain enhanced 
Raman signal, and are coupled to antibodies for localizing cancer 
markers such as PLC1. [11] Rhodamine derivatives have 
received significant attention as fluorescent sensors due to their 
visible absorption and emission wavelengths, large absorption 
coefficients, and high quantum yields. [12] They have been used 
in a wide range of applications, having great success as 
chemosensors (both in vitro and in vivo),[13,14] and dual-modal 
imaging agents.[15,16,10] Mitochondria present excellent targets 
for molecular imaging of cancer, It is known that the mitochondrial 
potential in cancer cells is greater than that of healthy cells,[17] 
and the design of a probe that can accumulate in these energized 
mitochondria will lead to a tumor-targeting agent. In recent years 
derivatives of rhodamine have been successfully shown to 
localise with the mitochondria of tumour cells, [18-20] as their 
cationic form localises as a result of the increased negative 
mitochondrial potential.[21-23] Under acidic conditions, the 
rhodamine moiety exists in its highly fluorescent pink-coloured 
form. As the pH increases the structure converts to form a 
spirocyclic ring, which is colourless and non-fluorescent. This 
ring-formation mechanism of rhodamine has also led to its 
extensive use as a pH-sensitive probe as well as chemosensor 
for metal detection. [24-26]. Herein we show the first multimodal 
SERS/fluorescent probe based on AuNPs and thiol rhodamine 
derivative that localises within mitochondria. 
 
Results and discussion 
 
We present a AuNP-Rhodamine conjugate exhibiting Raman 
enhancement and pH dependent fluorescence, which shows 
localisation within the mitochondria of cells. The dual modal probe 
AuNP.3 was formed in four steps: the synthesis of the AuNP and 
rhodamine thiol ligand followed by surface functionalisation 
(Scheme 1). The monodisperse AuNPs were synthesised using 
the Turkevich method [27, 28] to yield citrate coated AuNPs of 
diameter 12 nm ± 1.5 nm, determined by TEM (Figure S20). It was 
found that the plasmonic resonance of the citrate capped AuNPs 
peaks at a wavelength of 521 nm (Figure 1). The second 
component of AuNP.3 is the rhodamine thiol derivative, which 
was synthesised in a two-step method. The first step is the 
addition of an amino functionalisation for coupling to the lipoic acid. 
This amino functionalisation was undertaken on the phenyl 
carboxylate of 1, through the means of an amide bond formation 
with ethylenediamine, resulting in product 2 with a yield of 84%. 
The second step involved the addition of a lipoic acid through the 
formation of an amide bond to give compound 3 with a yield of 
29%, under standard coupling condition with the carbodiimide N-
Ethyl-N’-(3-dimethylaminopropyl)carbodiimide, and 4-
Dimethylaminopyridine as the base. The dithiol on the lipoic acid 
allowed the molecule to attach to the nanoparticle through two 
strong Au-S bond. It should be noted that the addition of the lipoic 
acid reduced the solubility of 3 in water. The photophysical 
properties of 3 were found to be similar to the standard rhodamine 
derivatives with an emission maxima at a wavelength of 582 nm 
when excited at the maximum absorption peak of 565 nm (Figure 
1). The small Stokes shift of ~ 20 nm, is expected as the 
fluorescence of rhodamine which has been extensively studied. 
[29] Ligand exchange was undertaken in a 1:1 mixture of 
methanol water with a pH range of 7-8 to replace the citrate 
coating of the AuNPs with 3. Tris(2-carboxyethyl)phosphine) 
(TCEP) was added to reduce the dithiol bond, keeping the pH high 
enough as not to protonate the free thiols of 3, allowing for 
functionalisation to the surface of the AuNP to produce AuNP.3. 
This ligand exchange method had already been successfully used 
with lipoic acid Gd(III) chelate derivatives on quantum dots. 
[30,31] Thermogravimetric analysis (TGA) of AuNP.3 shows that 
there are approximately 2264 ligands on the surface of each 
AuNP. This was confirmed by absorption spectra which yielded a 
result of 2398 ligands per nanoparticle (Figure S17). Infrared (IR) 
  
 
 
 
 
absorption spectroscopy confirms the presence of 3 on the 
surface of the product AuNP.3,  
Figure 2. (A) pH-mediated ring opening of the intramolecular sprirolactam of 
AuNP.3, yielding a highly fluorescent species. (B) pH-dependent emission 
spectra of AuNP.3 (λex = 535 nm, λem = 570 nm); (C) pH titration curve used 
to determine pKa of 3 and AuNP.3. 
(Figure S22). The rhodamine functionalised AuNP AuNP.3 acts 
as a multimodal SERS/fluorescence imaging probe with pH 
sensitivity. The optical properties of both 3 and AuNP.3 were 
investigated at various pHs. It was found that the emission 
intensity of 3 increased in more acidic conditions. As the pH is 
lowered the spirolactam ring of the molecule opens, yielding a 
greater fluorescence (Figure S23), as observed in other 
rhodamine conjugates. [10,32] Correspondingly, the quantum 
yield of 3 at pH 7.5 was found to be 16.6% while at pH 4.3 it was 
25.9%. A titration curve was produced by plotting the emission 
maxima of 3 at 582nm as a function of pH, yielding a pKa value 
of 4.59, which is comparable to that of rhodamine DOTA 
conjugates with pKa of 5.5. [10,32] However in the case of 
AuNP.3 the opposite effect is observed with a higher fluorescence 
emission observed at high pH rather than low pH, corresponding 
to a quantum yield of 0.8% at a pH of 8.1, and 0.2% at pH 5.1. 
The inverse pH response also shows a shift of the pKa from 4.59 
to 6.62 (Figure 2c) on the AuNP. This pKa is ideal for responsive 
imaging in biological applications (pH range from 6.5-7.4). This 
switch in pH sensitivity could be due to the change in localized 
charge about the AuNP, reflected in the zeta potential of AuNP.3 
which ranges from +18 mV at pH 5.2 to -60 mV at pH 7.8. This 
change in charge occurs when the spirolactam ring opens upon 
protonation at low pH (Figure S19) making it more positive. 
Additionally, the emission maximum of AuNP.3 was shifted to a 
wavelength of 570 nm in comparison to 582 nm for 3. This blue-
shift in emission after speciation is due to the change in the 
photonic environment around the ligand as a result of binding to 
the surface of gold (Figure 1/S24). Sun et. al. have shown that 
conjugation of pH insensitive dyes such as TAMRA to ultra-small 
AuNPs can enhance the pH sensitivity fluorescence properties of 
the dyes, but also broaden the pH range of fluorescein, 
suggesting changes in local surface charges after dye 
dimerization for this. [33]  
The lifetime of 3 shows two distinct components, representing two 
different decay rates. At low pH (3.82), and higher quantum yield, 
there is a slow component with a lifetime of 2.44 ns having a 
weighting of 63%, with the remaining 37% corresponding to the 
fast component of 0.58 ns. However as the pH is increased (6.26) 
and the quantum yield decreases, the lactam ring is formed and 
the weighting of each channel is reversed as 31% now 
corresponds to a fluorescence lifetime of 2.37 ns and 69% to a 
lifetime of 0.34 ns. This change in lifetime along with the evolution 
of the quantum yield with pH clearly illustrates the increase of a 
non-radiative decay channel with protonation of the ligand.  
The lifetime of 3 was also measured in a series of solvents (Table 
S1) including ethanol where it was found that 93% of the 
fluorescence corresponds to a lifetime of 1.34 ns with the 
Table 1. Lifetime of AuNP.3 at high and low pH at 530nm and 570nm. 
  530 nm 575 nm 
pH 4.31 Lifetime (ps) <100 1700 611 2200 
 Weighting 92 % 8% 31% 69% 
pH 8.16 Lifetime (ps) <100  1400 657 2800 
 Weighting 85%  15% 42% 58% 
  
 
 
 
 
remaining corresponding to a lifetime of 2.13 ns, which is in 
agreement to reported values for rhodamine B. The observed 
change of the fluorescence lifetimes with the solvent, indicates 
solvent quenching effects on 3, particularly in water (Table S1).  
Due to the emission shift of AuNP.3, and in order to quantify the 
coupling to the plasmonic resonance, the lifetime of AuNP.3 was 
measured at emission wavelengths 530 nm (corresponding to a 
full overlap with the LSPR of the AuNP) and 575 nm 
(corresponding to the tail of the LSPR) (Table 1). Both at low and 
high pH, the lifetime is reduced from ~600 ps away from the 
plasmonic resonance (575 nm) to below 100 ps (limited by the 
instrument response) on the plasmonic resonance (530 nm). 
Along with the decrease in emission intensity, the reduced lifetime 
of AuNP.3 around the plasmonic resonance (table 1), shows that 
the fluorescence is being increasingly quenched by the AuNP as 
the spectral overlap with the plasmonic resonance increases. This 
is also consistent with the evolution of the emission spectrum of 
AuNP.3, as the intensity at a wavelength of 530 nm decreases 
faster with pH compared to a wavelength of 575 nm. Additionally, 
it can be seen that the weight of the fast component (sub-100 ps) 
is reduced as the pH is increased, in agreement with the reversed 
pH curve of AuNP.3 with respect to 3. 
 
Figure 3. Raman spectra of 3 (dash lines) and AuNP.3 (solid 
lines), at low pH (red), and high pH (black). 
 
Raman spectroscopy of 3 and AuNP.3 deposited on a glass slide 
(Figure 3) shows clear enhancement of the characteristic 
rhodamine Raman scattering signals, such as the aromatic C–C 
bending and C-C stretching at 1638 cm-1 and the Aromatic C–H 
bending at 1500 cm-1, [34] when attached to the AuNP surface 
AuNP.3 compared to the control sample prepared from the 
ligands on their own, 3, indicating that AuNP.3 has the potential 
to work as dual modal SERS/fluorescence probe. 
 
Thus far we have shown that AuNP.3 give both pH dependent 
emission via fluorescence with the switch occurring at a pH of 
6.62 and enhanced Raman signal. To show that it can be used as 
an imaging tool AuNP.3 was incubated with Human Embryonic 
Kidney (HEK 293) (figure S26-31), Min-6 cells (Figure S37-42) 
and Ovarian Cancer (A2780) cells (Figure 4, Figure S32-36). This 
was to primarily show that the nanoconstruct would go inside cells 
and that the rhodamine ligand would direct it to the mitochondria 
to allow for potential cancer imaging. As can be seen in Figure 4, 
AuNP.3 enters the cells within 90 minutes and is localised inside 
the mitochondria. This is confirmed by the use of Mitotracker deep 
red. There is no co-localisation with the lysotracker blue 
confirming localization in the mitochondria of all cell lines studied. 
It is postulated that the charge of the AuNP.3 is thought to direct 
the nanoparticle to the mitochondria.  This has been seen with the 
smaller molecule dual modal agents, where charge is important 
to intracellular localization of the probe. [35] It can be postulated 
that this entrance is through endocytosis as most of AuNP.3 
appears in vesicular structures and is too big to diffuse through 
the cell membrane. MTT studies also show AuNP.3 to be non-
toxic at concentrations used for imaging (Figure S25), with IC50 in 
the millimolar range (12 mM [Au]). In comparison to Rhodamine 
6G AuNP based probes which have shown internalisation into 
endothelial cells [36], AuNP.3 shows localization to the 
mitochondria in three different cell lines, thus giving a 
mitochondrial targeted multimodal probe. 
 
Figure 4. Co-localisation of AuNP.3 in A2780 cells via confocal 
microscopy. A) Lyso-tracker staining, B) AuNP.3, C) Mito-tracker 
staining and D) overlay. (RPMI 1640 media, 298K) 
Conclusions 
We describe a dual-modal SERS/fluorescence imaging agent that 
is pH sensitive, with excellent fluorescent and Raman properties, 
which may potentially be used to monitor mitochondria in cancer. 
The dual-modal probes AuNP.3 show fluorescence changes with 
a large shift in the emission spectrum, from em = 582 nm to em = 
570 nm upon surface functionalization to AuNPs of 12 nm in 
diameter. The second advantage that arises from 
functionalization to the AuNP is an inverse in pH dependent 
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emission, with high emission observed at basic pH and low signal 
intensity at acidic pH with a pKa of 6.62. Compared to 3 which 
has a pKa of 4.59, with high emission seen at acidic pH. AuNP.3 
also show significant Surface Enhanced Raman Scattering 
(SERS) compared to 3. When examined in cell lines, (HEK293, 
Min-6 and A2780) AuNP.3 showed localization to mitochondria, 
and relatively poor uptake into other vesicles inside the cells, 
reflecting excellent cell permeability and localization to the energy 
centers of the cell.  This gives the option to take AuNP.3 forward 
as a multimodal SERS/fluorescent probe for mitochondrial 
imaging, in particularly for cancer, although further validation is 
required. We therefore believe that AuNP.3 provides a first stage 
model for the preparation of probes which may ultimately be of 
clinical utility. 
Experimental Section 
Reagents 
Rhodamine B, Lipoic acid, 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide 
(EDCI), 4-Dimethylaminopyridine (DMAP), HAuCl4 and Trisodium citrate 
were obtained from Sigma-Aldrich. HPLC water was used throughout and 
purchased from VWR chemicals.  
Apparatus 
The Transmission Electron Microscope used was a JEOL 2010 
Transmission Electron Microscope at 200kV, the images were taken with 
a Gatan US4000 camera. FTIR spectra was taken on Perkin Elmer Rx 
FTIR x2 with diamond ATR, DRIFT attachment. Zeta potential was taken 
on Malvern, Zetasizer Nano-z5. Cellular imaging was taken on a Zeiss 
LSM 710 Confocal scanning microscope. 
Fluorescence Measurements 
All fluorescence measurements were made with a Horiba Fluoromax-4P 
spectrofluorometer in a 10 mm quartz cuvette. All spectra was taken in 
either aqueous or ethanolic solutions depending on solubility. 
Fluorescence quantum yields were obtained using a previous reported 
method using a reference compound of rhodamine B in ethanol.  
The lifetime was measured in a 10 mm quartz cuvette. Exciting at 532 nm 
for 3 and 485 nm for AuNP.3. The emission was collected at 575 nm and 
530 nm for both off and on the plasmonic resonance respectively using a 
Becker and Hickl HPM-100 detector. 
pH Titration 
A 0.15mM solution of 3 in 0.1M KCl (2ml) was prepared and then added 
to a 10mm quartz cuvette. The pH was monitored using a digital pH meter 
(Jenway 3520) with a glass electrode (Mettler Toledo 51343160). The pH 
was adjusted to 8.5 using 1mM NaOH solution then lowered to acidic 
conditions by adding small aliquots of 1mM HCl. Fluorescence spectra was 
taken for a range of pH with a 3nm excitation slit width, 1nm emission slit 
and 0.5s acquisition time. This was repeated for AuNP.3 under the same 
conditions. 
Raman 
For Raman measurements, the samples were prepared through spin-
coating a thin layer of either 3 or AuNP.3 onto glass substrates at a speed 
of 500rpm for 30 secs. Raman measurements were taken using a Raman 
setup equipped with a 532 nm DPSS laser to excite the samples. Raman 
signal was collected using a 0.55NA, 50x objective lens then directed 
toward a Horiba i320 spectrometer that coupled to a nitrogen cooled 
symphony CCD. In all measurements we used a 10 mW excitation power, 
an acquisition time of 5s and a spectrometer slit width of 0.1mm. 
Gold nanoparticle synthesis 
Spherical 15nm gold nanoparticles were prepared by citrate reduction of 
HAuCl4 according to literature [37]. The synthesis is as follows; Gold 
hydrochlorate (7mg, 0.8nmol) is added into 20mL of an aqueous solution. 
This is then heated to 75°C in a 3 neck round bottom flask by means of a 
heating mantle to ensure a homogenous temperature. The liquid is 
vigorously stirred using a magnetic stirrer. In a separate round bottom flask 
a further 20mL of aqueous solution is heated with the addition of trisodium 
citrate (40mg, 7.7mmol). When the gold hydrochlorate solution has come 
to the boil the preheated trisodium citrate is then added. The solution 
quickly turns to a wine-red as the nanoparticles increase in size. To 
prevent aggregation the solution was left to stir for 40mins then span down 
in a centrifuge at 13300rpm for 20 minutes at a low temperature. As the 
reaction is temperature dependent this stops the reaction causing the 
citrate to cap the nanoparticle and avoid the nanoparticles aggregating. It 
was found after 20 minutes the nanoparticles had reached the maximum 
size of 15nm. From TEM and extinction spectra the nanoparticles are more 
spherical and monodisperse after a time of 40 minutes.  
Ligand synthesis  
NMR was obtained using Oxford A4500 at 400MHz. Mass spectroscopy 
was obtained using Avion Expression CMS with a Hitachi chromaster 5110 
pump. 
2 was synthesised as follows. Rhodamine B (4.8g, 10mmol) was dissolved 
in EtOH (30ml). Ethylenediamine (4.48g, 13mmol) was added dropwise. 
The reaction mixture was heated to reflux temperatures for 15 hours until 
it loses its red colour. The solvent was removed in vacuo. Water is then 
added to the resultant and extracted in Dichloromethane. The compound 
was washed twice with water and dried over Magnesium sulfate. The 
solvent was removed again in vacuo yielding compound (1). 1H NMR 
(400MHz, CDCL3): δ 1.16 (t, 14H, 3JHH = 7.04Hz), 2.40 (t, 2H, 3JHH = 
6.53Hz), 3.18 (t, 2H, 3JHH = 6.53Hz), 3.30-3.36 (m, 9H), 6.25-6.28 (m, 
2H), 6.37(d, 2H, 3JHH = 2.56Hz), 6.42 (s, 1H), 6.44 (s, 1H), 7.08-7.10 (m, 
1H), 7.42-7.46 (m, 2H), 7.88-7.92 (m, 1H). 13C NMR (100MHz, CDCl3): 
12.65, 40.94, 43.92, 44.49, 64.96, 97.80, 105.76, 108.17, 122.81, 123.95, 
128.07, 128.79, 131.34, 132.48, 148.83, 153.38, 168.73. ESI-HRMS: 
calcd for C30H37N4O2 485.29, found m/z 485.85. 
3 was synthesised as follows. This is achieved by creating a mixture of 
compound (2) (100mg, 0.222mmol), (45.7mg, 0.222mmol) lipoic acid, 1-
Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDCI) (42.6mg, 
0.222mmol) and 4-Dimethylaminopyridine (DMAP) (27.2mg, 0.222mmol) 
were dissolved in  1:1 ratio of Acetonitrile : Dimethylformamide (DMF) 
(5ml). This solution was stirred for 18 hours in which a white precipitate 
formed corresponding to the DMAP salt. The solution was filtered and 
purified by silica gel chromatography with 1-5% MeOH/DCM. 1H NMR 
(400MHz, CDCl3): δ 1.17 (t, 12H, NCH2CH3, 3JHH = 7.14Hz), 1.37-1.47 
(m, 2H), 1.58-1.71 (m, 4H), 1.85-1.93 (m, 1H), 2.09 (t, 2H, COCH2CH2R, 
3JHH = 7.51Hz), 2.40-2.47 (m, 1H), 3.03-3.19 (m, 4H), 3.28-3.36 (m, 10H), 
3.51-3.58 (m, 1H), 6.26-6.29 (m, 2H), 6.37 (d, 2H, 3JHH = 2.38Hz), 6.41-
6.44 (m, 2H), 6.88-6.9 (m, 1H), 7.07-7.09 (m, 1H), 7.45-7.47 (m, 2H), 7.89-
7.91 (m, 1H), 8.02 (s, 1H). 13C NMR (100MHz, CDCl3): 12.77, 25.45, 
29.04, 34.94, 36.52, 38.54, 40.27, 40.84, 44.44, 56.53, 65.74, 97.84, 
  
 
 
 
 
104.75, 108.35, 122.89, 124.04, 128.50, 130.52, 132.96, 148.94, 153.40, 
153.98, 170.10, 172.69. ESI-HRMS: calcd for C38H49N4O3S2 673.32, 
found m/z 673.52.  
Ligand Exchange 
The AuNPs surfaces were modified to obtain AuNP.3. The rhodamine thiol 
was bound to the nanoparticle surface by Au-S bonding. This was obtained 
by mixing together Au Np (2.5mg, 0.18nmol), RhB thiol (1.18mg, 1.8umol) 
and TCEP (5.03mg, 18umol). A solution of methanol (0.5ml) and HPLC 
water (3.5ml) was added and the pH adjusted between 7 and 8.  The 
solution was then left to stir overnight at room temperature. The resultant 
was then span down at 6000rpm for 2 minutes and repeated until the 
suspension was clear, resuspended in water and sonicated. The 
fluorescence spectra was obtained at room temperature exciting at 535nm 
which is the maximum excitation for the probe and at 565nm, the maximum 
excitation for the ligand. The low emission was evidence that the RhB 
molecule had attached to the nanoparticle surface and was being 
quenched by the Au. The spectra was also evidence that no excess 
rhodamine was in the sample.  
In Vitro studies 
The A2780, Min6 and HEK cells were washed and resuspended in RPMI 
1640 and DMEM respectively. The cells were then loaded into Starstedt 
lumox dish 35 and left to grow overnight in 2ml of RPMI 1640 and DMEM. 
They were then washed twice with PBS and then incubated with RPMI 
1640 medium or DMEM, 100µl of the nanoparticles suspended in water at 
a concentration of 5.4x1013 nanoparticles per ml, 4µl of lysotracker, 
mitotracker and DAPI. After an hour and half all media and dyes were 
removed. The cells were then washed with PBS and PFT was added to fix 
the cells. After ten minutes incubation at room temperature, the PFT was 
removed and the cells washed again with PBS and stored in PBS at 4 
degrees. They were imaged using a Zeiss LSM 710 Confocal scanning 
microscope. 
MTT Assay 
To determine cell viability the MTT metabolic assay was used. A2780 cells 
were cultured in a 96-well plate at 37°C for 24 hours and then exposed to 
varying concentrations of AuNP.3 for a further 24 hours. Due to the small 
overlap in absorbance a control was ran of just media and nanoparticles 
to eliminate any absorbance from the nanoparticles.  A solution of MTT (5 
mg ml-1 in PBS) was added to each well and left to incubate for a further 4 
hours. All the media was then removed and the plates washed with PBS. 
The resultant formazan crystals were dissolved in Dimethyl sulfoxide and 
the absorbance measured at 570nm and 690 nm.   
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